• Annual revenue growth from $75 million in 2012 to $166 million in 2017
• YGYI selected by NASDAQ as Fit Week Company in January 2018; added to Russell Index in June 2018
• Youngevity’s strong presence in large, scalable, top global vertical market segments includes the $216 billion anti-aging sector, $154 billion skin care space, $11.6 billion brain health market, and $241 billion weight loss industry
• International expansion well underway with corporate infrastructure, product approvals, newly acquired distributors and customers now driving revenue
• CLR Roaster has entered into a 5-year contract with a major coffee important and exporter for the sale and processing of over 41 million pounds of green coffee on an annual basis; contract is estimated to generate revenues of $250 million from 2019 through 2023, with first shipments beginning January 2019

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

• Health and Nutrition
• Home and Family
• Food and Beverage
• Spa and Beauty
• Fashion
• Essential Oils
• Photo and scrapbooking
• Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

For more information, visit the company’s website at www.YGYI.com

• Chile’s lithium exports reached $85 million in July, more than double that of the same month last year
• Exploratory drilling at Ollague discovers a major zone of brine 110 meters below surface in first hole
• Lithium Chile wholly owns 152,900 hectares in the world’s highest-grade lithium district making it the largest lithium project landholder outside of the government and SQM

Chile’s lithium exports are soaring, with production hitting $85 million in July, more than double that of July 2017. Additionally, the country’s lithium revenues have gone up more than 51 percent since the start of 2018 (http://ibn.fm/eKT7s).

The largest private owner of lithium-rich land in the South American country, Lithium Chile, Inc. (TSX.V: LITH) (OTCQB: LTMCF) is continuing its progress toward taking a serious stake in this fast-growing market, with exploratory drilling at its wholly owned Ollague property yielding promising results. The company recently released an update on the work at the property and reported that a 180-meter zone of brine has been found just 110 meters below the surface (http://ibn.fm/6kGuS). Samples of this brine are currently being assayed by an internationally-accredited laboratory to identify the presence of lithium and assess its concentration.

Lithium Chile director and expert in the South American lithium sector, Andrew Bowering explained that, while 70 percent of the world’s lithium occurs in Bolivia, Argentina and Chile, Bolivia does not allow foreign ownership and therefore no lithium production comes out of that country, and Argentina has significantly lower lithium grades than Chile, with less overall lithium and less opportunity. “We’re going to see a lot more foreign investment coming into Chile as a result of changing mining conditions,” Bowering said in a news release.

Chile also has the lowest lithium production costs in the world. Australia, for example, another of the world’s largest producers, has to extract lithium out of hard rock. This costs magnitudes more than in Chile, whose lithium reserves are held in brine found underneath the country’s northern salt flats.

Lithium Chile owns 15 projects in the world’s highest-grade lithium district. The company fully owns 152,900 hectares located within 14 salars and one laguna complex. The samples taken to date are very promising, and this is just the first drill hole of what is set to be a multi-project program. With $8 million in working capital and exploration well underway, the company is aiming for resource estimates later this year.

“After amassing one of the largest lithium land packages in Chile, we have now begun drilling on one of our more advanced projects which have had sampling and geophysics completed on them,” Lithium Chile President and CEO Steve Cochrane said in a news release. “The new government has been clear in its support for the lithium sector and we are similarly encouraged by the strong community support we have received. This is an exciting new growth phase for the Company and our goal is to maximize our early-mover exploration advantage in Chile.”

Lithium Chile has assembled a team of industry heavyweights to lead it forward as it realizes its potential. Between them, the team has accumulated many decades of experience in the natural resources and mineral exploration sectors. Crucially, it also has excellent in-country connections thanks to its VP of exploration and chief geologist, Terry Walker, who has been based in Chile for the last 25 years. These connections have enabled the company to get community support for its drill programs and start drilling while competing explorers have yet to mobilize a single drill rig.

The rise in electric vehicles is fueling world lithium demand, since lithium is a key component of the batteries that power these vehicles. Some industry experts estimate that 80 percent of all new vehicle sales will be electric within the next 15 years. Numerous governments around the world, including heavyweights like China, are throwing their weight behind the electric vehicle revolution. A number have already legislated future bans on gas-driven cars within the next two decades, and others are planning similar bans. According to Grand View Research, the global lithium-ion battery market is expected to reach $93.1 billion by 2025, growing at a CAGR of 17 percent (http://ibn.fm/yJ5sI).

For more information, visit the company’s website at http://ibn.fm/LTMCF

• DehydraTECH™ methodology offers safer alternative to smoking
• Possible nicotine delivery platform for Big Tobacco
• Several licensing agreements for technology already signed

Formula One racing is not the only place to find speed. The drug delivery platform DehydraTECH™, developed by Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has proven that it’s just as fast. In recent in vivo tests, the technology delivered 203 nanograms per milliliter (ng/mL) of nicotine in 15 minutes, 70 percent more than the control. Such rapidity may rival smoking; particularly as new research (http://ibn.fm/cvW29) suggests that “nicotine takes much longer than previously thought to reach peak levels in the brains of cigarette smokers.” For tobacco industry giants on the search for safer delivery methods than smoking, the DehydraTECH™ platform is increasingly beginning to look like an attractive alternative.

Earlier in August, Lexaria announced the results of its second in vivo study of 2018, evaluating the use of DehydraTECH as a nicotine delivery system (http://ibn.fm/riRAx). The company revealed that it had successfully transported nicotine in an edible form into blood plasma just minutes after dosing in an animal in vivo study. Its DehydraTECH technology delivered nicotine at each of the two-, four-, six-, eight- and 10-minute intervals post-dosing, with 90.2 percent greater delivery than the concentration-matched control formulation by the 10-minute mark (95 percent CI; p=0.044) and significantly greater absorption levels than the control formulation at all subsequent time points in the study.

Rapidity of delivery was notable; nicotine was detected in the first blood sampling at the two-minute mark. On average, Lexaria’s technology delivered 203 ng/mL to the blood in aggregate of the two-, four-, six-, eight-, 10-, 12- and 15-minute time points, compared to only 120 ng/mL in aggregate over the same period by the control, an improvement of 70 percent (95 percent CI; p=0.0004). This test represents Lexaria’s second in vivo nicotine study, building on the previous nicotine breakthrough study announced in April 2018. Its promising results are good news for Lexaria; as Big Tobacco continues its quest for ‘reduced-risk’ products, DehydraTECH may have a role to play (http://ibn.fm/7ofru).

The DehydraTECH drug delivery platform overcomes a serious limitation to nicotine ingestion. The human GI system struggles to process nicotine in the forms in which it is presently offered – one reason why there are currently no edible nicotine products available. However, DehydraTECH employs a patented, cost-effective delivery mechanism, employing lipophilic agents, that improves the bio-absorption and bioavailability of ingestible substances, as well as their taste and smell, as demonstrated by the recent in vivo studies.

Application of the technology extends beyond nicotine to non-psychoactive cannabinoids, vitamins and non-steroidal anti-inflammatory drugs (NSAIDs), and Lexaria has licensed the technology to a number of companies. These include chocolate maker Nuka Enterprises; cannabis beverage manufacturer GP Holdings; Biolog, which markets hemp-based, cannabidiol (CBD)-infused products and vitamins; and others.

Lexaria is expecting to sign more licensing agreements to enhance cannabinoid delivery before year-end 2018. These are typically six-figure contracts in the first year and potentially seven-figure contracts over the life of the deals. Licensing is a lucrative business model that typically yields 90-100 percent of revenues as profit. Lexaria is hopeful that its demonstrated speed of nicotine delivery will translate into technology licensing agreements for enhanced nicotine delivery. At present, the tobacco industry generates about 20 times more revenue than the cannabis industry, an indication that Lexaria’s DehydraTECH drug delivery platform may soon be available at your local smoke shop.

For more information, visit the company’s website at www.LexariaBioscience.com

• Increasing value, visibility and transparency by becoming an OTCQB fully reporting company
• High Grade Full Spectrum Cannabinoids Line being expanded to 90,000 retail outlets, with three additional chocolate products added to the line
• Distributing vapes/e-liquids and gummy edibles in the recreational sector
• MSN-2 home medical testing kit allows for the testing of sexually transmitted disease in the privacy of one’s own home

Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on cannabis and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices, has initiated the up-listing process in anticipation of its Form 10 Registration Statement being approved. By becoming a fully reporting company listed on the OTCQB Venture Market, the company expects to increase in value, visibility and transparency (http://ibn.fm/ROn48).

By up-listing in anticipation of the approval, the company is advancing its timeline to achieve fully reporting status. “Once ETST is an OTCQB fully reporting company, we will attract many new investors while keeping current shareholders pleased with our progress,” President, Director and Chairman of ETST Nickolas S. Tabraue stated in a news release. “We can now communicate with large-net-worth investors to acquire the needed funds to strengthen our High-Grade Full Spectrum Cannabinoids line, KannaBidioiD line and MSN-2 medical device and to exponentially increase our revenues overall.” The up-listing holds promise of new potential investors and the company has a number of exciting updates that it plans to share soon.

Investors can now help the company strengthen innovative, and exciting updates already in the works.

• ETST’s High Grade Full Spectrum Cannabinoids line is being introduced by AATAC, an advisory board focused on convenience stores, to its 90,000 retail outlets throughout the United States. In addition, three unique new chocolate products are being formulated with joint venture partner Karmavore Superfoods, bringing the company’s product line to five unique CBD Raw Chocolate flavors. The launch of these new CBD-based formulas is anticipated for the third quarter of 2018 (http://ibn.fm/wuhEW).
• KannaBidioiD, Inc. is a wholly owned subsidiary of ETST that manufactures and distributes vapes/e-liquids and gummy edibles in the recreational sector.
• ETST’s Earth Science Pharmaceutical subsidiary develops medical diagnostic tools which include the new MSN-2, a home medical testing kit. The kit is designed for the detection of sexually transmitted infections (STI), and the registration of the trademark is anticipated within the next nine to 10 months (http://ibn.fm/XWRUF).

Transparency is a key component in the expansion of ETST’s business as it maintains the confidence of investors and works toward becoming a fully reporting company listed on the OTCQB Venture Market.

For more information, visit the company’s website at www.EarthScienceTech.com

• Lithium Chile on second stage of four-hole drill project in the world’s highest-grade lithium jurisdiction
• Company expects to complete additional projects for assay by end of Q3
• Lithium demand from computerized electronics industry expected to remain strong during coming decade, with 650 percent growth forecast

The team at Lithium Chile, Inc. (TSX.V: LITH) (OTCQB: LTMCF) is excited by drilling progress at the company’s Salar de Ollague project in Chile. The first core and liquid samples from a four-hole drilling program on the property are being assayed (tested) for their potential in meeting electronic device battery needs across the planet.

Preliminary results from the first drill hole, announced on July 23, 2018, showed salinity in a zone between 110 and 290 meters deep. That’s 180 meters of brine, and the assays will identify any lithium content and determine the amount and the grade. Salars are dried lake beds, and the underground reservoirs of salt-rich brines found below such old lake beds have become a favorite target for mineral exploration. This is because the cost of extracting dissolved salts like lithium, potassium and sodium from the brines is far less than the cost of the historically favored hard rock extraction efforts.

How strong does the lithium brine need to be? Well, lithium brine is typically measured in parts per million (“ppm”), and this can alternatively be expressed as milligrams per liter (mg/L). At Albemarle’s massive lithium brine mine in the United States (http://ibn.fm/V2iZg), a concentration of lithium between 190 and 200 ppm has been sufficient for production. However, the first of Lithium Chile’s four drill holes is located about a kilometer from a test well where new fluid samples were recently assayed at 1,220 mg/L of lithium, according to a company news release (http://ibn.fm/0Ojjq). That 600 percent higher than Albermarle’s U.S. operation.

The samples taken from the first hole are being assayed at internationally-accredited laboratory ALS Patagonia’s nearby facilities in northern Chile for a chemical analysis that determines the concentration of lithium in the brine. Drilling has begun at the second hole, two kilometers southwest of the first.

The Ollague salar is 3,500 hectares (8,648.7 acres) in size. Lithium Chile’s portfolio includes 14 salar explorations and one laguna (surface water) complex, which makes it the largest lithium resource property owner in Chile, outside of SQM and the government itself. Due to its high grades and the sheer size of its lithium reserves, Chile is the most important player in the famed Lithium Triangle of Chile, Bolivia and Argentina, where 75 percent of the world’s available lithium is located. When Lithium Chile completes the four-hole drilling project that began in June, it plans to start similar projects at four other advanced-stage sites, potentially wrapping up before the end of Q3.

Lithium’s critical importance to the low-heat, lightweight batteries that supply high-energy outputs to the computerized electronics industry make it an attractive commodity with a forecast demand-supply imbalance that gives it a likelihood of strong pricing for the next decade. International metals and minerals research agency Roskill predicts that overall lithium demand will triple by 2027, with demand specific to the electronics industry rising 650 percent (http://ibn.fm/1Go2r).

This forecast reflects a change in consumption of the lightweight metal. While it has seen surging popularity in recent years for items such as mobile phones and laptop computers, global politics driving climate change policy are also creating a massive boom in electric vehicle and hybrid production and marketing. These regulatory shifts made the automotive industry the most influential entity affecting lithium industry forecasts last year, according to Roskill (http://ibn.fm/d5qGO).

“The new government (of Chile) has been clear in its support for the lithium sector and we are similarly encouraged by the strong community support we have received. This is an exciting new growth phase for the Company and our goal is to maximize our early-mover exploration advantage in Chile,” Lithium Chile President and CEO Steve Cochrane stated in a June news release (http://ibn.fm/m8Tue).

For more information, visit the company’s website at http://ibn.fm/LTMCF

• Majority of states have legalized marijuana in some form
• CSA creates financial barriers to cannabis sales, purchasing
• REFG pioneering payment solutions in rapidly expanding market

In what CNN analyst Z. Byron Wolf says may be a tipping point (http://ibn.fm/B8TKV), voters in Oklahoma — generally considered a politically conservative state — approved one of the most permissive medical marijuana initiatives in the country this summer. For those keeping track, that makes a total of 30 states and the District of Columbia (http://ibn.fm/4MArB) that now have laws broadly legalizing marijuana in some form. Once unimaginable, the legalization of the substance on a federal level is even looming as a possibility.

With this abrupt change in momentum comes unique challenges for companies looking to offer services to both providers and users of cannabis. One of the most significant challenges is payment for the plant.

Since President Richard Nixon signed the Controlled Substances Act (CSA) into law in 1970, medical marijuana has been categorized as a Schedule 1 substance. Consequently, the U.S. Federal Reserve System refuses to charter any financial institution that serves marijuana businesses (http://ibn.fm/wq3BD), creating an environment where even “transporting or transmitting funds known to have been derived from the distribution of marijuana is illegal.”

Known as a first-tier merchant processing cannabis industry pioneer, Medical Cannabis Payment Solutions (OTC: REFG) offers one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state-of-the-art system tracks sales and tax collection and eliminates the need to deal in cash-only transactions.

REFG’s unique ‘StateSourced’ proprietary system enables authorized operation under FinCEN parameters, ensuring compliance with all regulatory frameworks. The first operation of its kind targeting the legal cannabis industry, StateSourced provides the convenience of modern commercial card processing resources. Medical Cannabis Payment Solutions offers its StateSourced card on a state-by-state basis. The card can be used to purchase product from an authorized vendor, providing a much-needed option for consumers and businesses alike.

To further its pioneering efforts, the company is also collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s WeedCoin ($Weed) cryptocurrency with its StateSourced payment gateway. This intriguing collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and bitcoin.

In addition, Medical Cannabis Payment Solutions also allows merchant clients to sign up for payment-processing services online quickly and easily. Within minutes, clients can start collecting payments, move funds to other banks with no compliance issues or spend funds directly from their accounts. Finally, the company offers bank accounts for state-licensed medical marijuana establishments through its www.Take.Green website.

“We believe we offer the nation’s only truly compliant payment and banking solution for state-sanctioned marijuana,” REFG CEO Jeremy Roberts stated in a news release.

For more information, visit the company’s website at www.Take.Green

• Millions worldwide affected by sleep disorders
• Sleep disorder market set to exceed $50 billion by 2020
• New marketing initiative kicks off with engagement of IR firm
• Updated Crystal Equity Research report now available

Counting sheep may soon be a thing of the past, for PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has been awarded a worldwide license to manufacture, distribute and market three Health Canada-approved sleep aids (http://ibn.fm/rO8AV).  This milestone could not have come at a better time. Sleeping disorders affect around 40 percent of adults in Canada (approximately 15 million), according to a study conducted at the Université Laval, and the same unhappy state of affairs exists in the U.S. The America Sleep Association (ASA) estimates that at least 50 million American adults have a sleep disorder. All three of the products have undergone thorough testing and meet or exceed the requirements of the European Pharmacopoeia and Health Canada.

The Canadian study was led by Dr. Charles M. Morin, known for his work developing non-pharmacological therapies, such as cognitive-behavioral therapy (CBT), to treat insomnia. After surveying some 2,000 Canadians (http://ibn.fm/WXAYw), Morin’s team found that “40% of respondents had experienced one or more symptoms of insomnia at least three times a week in the preceding month, i.e., taking more than 30 minutes to fall asleep, being awake for periods longer than 30 minutes during the night, or waking up at least 30 minutes before they had planned. Moreover, 20% of the participants said they were unsatisfied with the quality of their sleep, and 13.4% of respondents displayed all the symptoms required to diagnose insomnia.”

Such alarming statistics point to an underserved market, despite the plethora of sleep aid products available. “Americans spent an estimated $41 billion on sleep aids and remedies in 2015, and that’s expected to grow to $52 billion by 2020”, according to figures cited by Consumer Reports (http://ibn.fm/U9oHj).

The three Natural Health Products (NHPs) to be manufactured and marketed under the Licensing Agreement with Asterion Cannabis Inc. are ‘Blissful Sleep’, ‘Blissful Sleep Ex.’ and ‘Skullcap Serenity’. The deal allows PRVCF to use Asterion’s intellectual property (IP) to make or have made, use, distribute, sell, offer to sell and promote the products for an initial term of five years, renewable for five consecutive one-year terms. PreveCeutical will pay Asterion a royalty equal to 20 percent of the gross product sales.

The ingredients of the products under license are some traditionally used in herbal medicine as non-addictive sleep aids. Blissful Sleep and Blissful Sleep Ex contain hops (Humulus lupulus) and root of valerian (Valeriana officinalis), while Skullcap Serenity contains powdered or extracted American Skullcap (Scutellaria lateriflora) leaves. Skullcap Serenity’s ingredients have been used in the past to calm nervousness and alleviate pain associated with menstrual cramps. For consumers using cannabis to relieve anxiety or to aid sleep, the products can be used as complementary therapies.

A recently released update of coverage for PreveCeutical is available at Crystal Equity Research (http://ibn.fm/BkN2J).

For more information, visit the company’s website at www.PreveCeutical.com

• Acquisition includes 100 percent of issued and outstanding shares of privately-held HemPoland in an immediate accretive cash and share transaction worth $15.5 million with an additional $10.3 million committed to R&D, global expansion
• Agreement opens European gateway with distribution channels to over 750 million people and sales in over 700 locations across 13 countries
• In 2017, HemPoland produced more than 32,000 kg of organic dried flower and 310 kg of organic CBD oils from over 1,250 acres of cultivation
• Deal accelerates TGOD’s strategic plan to become the world’s largest organic cannabis brand

In a move that dramatically accelerates its strategic entry into Europe’s lucrative organic cannabis market, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) announced on Tuesday that it has entered into a definitive agreement to acquire HemPoland, a European manufacturer and marketer of premium organic CBD oils (http://ibn.fm/tfHhi). The $25.8 million deal, which includes an immediate accretive cash and share transaction in addition to an infusion of funding for research and development, gives the cannabis-focused research and development company an enviable foothold in Europe’s multibillion dollar cannabis market, as detailed by Brian Athaide, CEO of TGOD.

“HemPoland is a key component to a number of strategic acquisitions and planned partnerships focused on expanding our global distribution network. This acquisition will significantly add to the Company’s top and bottom line,” Athaide said in announcing the agreement. “Gaining market share with CBD products now, in the EU, with over 700 locations allows TGOD to establish immediate brand awareness across all verticals including infused beverages. This is an accretive acquisition and gateway to Europe’s 750 million people accelerating our plan of becoming the world’s largest organic cannabis brand.”

Global spending on legal cannabis products is projected to grow from $20 billion in 2018 to more than $63 billion by 2024, according to Statista (http://ibn.fm/aNowu). Growth in the recreational and medical cannabis space continues to pick up steam as countries around the world adjust regulatory guidelines and define laws allowing cannabis products to be sold and consumed. In October, the world will be watching as Canada becomes the first G7 country to legalize recreational cannabis nationwide.

HemPoland, a leading European manufacturer and marketer of premium organic CBD oils, is led by one of Europe’s most widely recognized CBD experts, founder and CEO Maciej Kowalski. This strategic acquisition provides TGOD with access to HemPoland’s vast distribution network, premium Cannabigold brand and state-of-the-art hemp oil extraction technologies, in addition to an established pathway into the European market for TGOD’s medical and recreational products and licensing deals.

“We are pleased to join forces with the premier brand in organic cannabis, TGOD, to scale the growth of our business both domestically and internationally,” Kowalski said in a joint news release. “The market and demand for premium organic cannabis and CBD oil is just the beginning, ultimately leading to a variety of higher margin products. Having access to TGOD’s capital, licensing deals, experienced leadership team, and intellectual property will significantly drive momentum for our brand and our company. We are proud to be part of the TGOD family and look forward to becoming the global leaders in organic cannabis.”

HemPoland was the first company in Poland to obtain a state license allowing it to grow hemp and manufacture CBD oil products. The company is vertically integrated with over 1,250 acres of cultivation and multiple commercial scale extraction units, producing more than 32,000 kg of organic dried flower and 310 kg of organic CBD oils. Since its founding in 2014, HemPoland’s expanding distribution network, diverse wholesale model and robust ecommerce platform has allowed the company to grow quickly across the European Union.

The acquisition cost is comprised of $7.75 million in cash and 1,968,323 restricted TGOD shares presently worth $7.75 million, with an additional $10.3 million cash investment to further product development, fund research and development and continue rapid European expansion. The closing of this transaction is subject to customary closing conditions and the approval of the Toronto Stock Exchange.

Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team and dedication to organic farming and principles. Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence.

For more information, visit the company’s website at www.TGOD.ca

• ATHC subsidiary adds low-cost credit card processing, business solutions programs amid heightened marketing efforts
• Company adds loan assets to increase funding for alternate lending clients
• President anticipates revenue generation in Q3 amid drive to serve entrepreneurs, boost synergy among subsidiaries

As end-to-end business solutions company Accelerated Technologies Holding Corp. (OTC: ATHC) advances its portfolio toward revenue generation, it is expanding the low-cost merchant services that it makes available to small- and mid-sized businesses (SMBs) through subsidiary Intelagy (http://ibn.fm/nm18t). Intelagy offers affordable subscription-based credit card processing, branding, marketing and analytical tools to SMB owners that better enable them to compete in today’s market environment with resources that may typically be more available to bigger players.

In a July 31 news release announcing the filing of Accelerated Technologies Holding’s Q2 financials (http://ibn.fm/pKUkl), the company noted that Intelagy launched the first of many marketing campaigns for its services amid the expansion of its payment processing project. It also reported that subsidiary FinBridge, which provides loan capital to independent sales organization (ISO) and merchant cash advance (MCA) lenders, posted about $250,000 in loan funding (http://ibn.fm/HCkve) in a boost to company assets, and that ATHC has completed its proprietary customer relationship management (CRM) systems to help its clients use data analysis to boost their relationships with current and potential customers.

“We are pleased to inform shareholders that we are ahead of schedule in regard to executing our merchant servicing strategy and look forward to begin generating revenue via affordable subscription based small business solutions in Q3 as we continue to add shareholder value,” Accelerated Technologies Holding Corp. President Kevin Kading stated in a news release.

ATHC’s portfolio also includes subsidiaries XStreamCorp, a reality gaming social network that is adapting proprietary technologies to dramatically change the player experience in online gaming through streaming video, audio and messaging capabilities, and IconXchange, which aims to provide a decentralized, flexible infrastructure for human funding through blockchain-based coins and tokens.

The company provides consulting and technological resources along with venture capital to help entrepreneurs with potential to build great companies, particularly through the use of Internet-based cloud-computing, software as a service (SaaS), mobile dynamics, storage, databases and other back-end systems. With the addition of Intelagy to the family, Accelerated Technologies Holding will continue structuring in synergy between its subsidiaries to further establish enterprising solutions for SMBs while driving its own corporate growth to maximize shareholder value.

For more information, visit the company’s website at www.ATHCorp.com

• FinCanna advances $2.25 million to Refined Resin Technologies and ezGreen Compliance
• California sales account for one-third of U.S. cannabis market
• California market projected to grow by CAGR of 23 percent to $6.5 billion by 2020

California is now home to the largest legal cannabis market in the world. A pioneer of medical marijuana, which it legalized in 1998, the state has gone a step further by legalizing adult use of marijuana as of January 1, 2018. As a result, sales, already accounting for one-third of legal cannabis sales revenues in the U.S., are projected to reach $4.3 billion in 2018 and continue to grow to $6.5 billion by 2020, according to Arcview Research & New Frontier Data. But such rapid growth won’t be possible unless the industry can attract funding, which means that the services provided by specialty financing company FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) will likely be in high demand. FinCanna Capital, a royalty company for the licensed U.S. medical cannabis industry, provides capital to licensed medical cannabis companies in exchange for a percentage of future cash flows under a royalty financing model.

FinCanna Capital might have taken a leaf from the mining industry playbook, since royalty companies, sometimes referred to as streaming companies, are active in the precious metals industry. They fund the exploration and production activities of miners and, in return, receive rights over a percentage of future revenue streams. FinCanna’s modus operandi will be similar. The company will provide upfront advances to cannabis companies in return for a future stream of royalty payments.

Royalty financing offers several benefits to startup cannabis companies. Compared to equity financing from private or public investors, it can be a more palatable solution for shareholders, since it requires no transfer or dilution of equity. Accordingly, owners are also at less risk of losing control of their businesses. In royalty financing, investors own a piece of the company’s revenue stream rather than a piece of the company itself.

Royalty financing may also be less burdensome than debt. With a loan or bond, interest payments are usually fixed and can be difficult to change if business conditions deteriorate. However, flexibility is built into the royalty financing structure, since royalty payments are linked to revenues or cash flows.

FinCanna is already making its presence felt. The company recently announced that it had advanced $1.25 million, an initial tranche of capital, to Refined Resin Technologies (http://ibn.fm/RxntR). Refined Resin is retrofitting a legally zoned, large, state-of-the-art medical cannabis extraction laboratory in Oakland, California, that’s expected to be in operation by late 2018 or early 2019. Refined Resin has extensive experience in extraction, manufacturing and business operations and intends to be premier producers of bulk quantities of THC (tetrahydrocannabinol) distillate and various high-value concentrates produced via hydrocarbon-based solvent extraction.

Around the same time, FinCanna also revealed that it had advanced $1 million to ezGreen Compliance, which offers a state-of-the-art enterprise compliance and point-of-sale software solution for licensed medical cannabis dispensaries and cultivators (http://ibn.fm/OqLBD).

FinCanna also announced the appointment of John Campbell to its advisory board. Campbell has over 35 years of experience in the investment industry, and currently serves as chairman and CFO of TriView Capital, one of Canada’s largest Exempt Market Dealers (http://ibn.fm/BhWGN).

FinCanna’s first investment in California, Cultivation Technologies, recently executed an agreement with Phoenix Tears LLC, to be the exclusive manufacturer and distributer of official Phoenix Tears THC-based products in California. The Phoenix Tears-branded portfolio of THC based products will initially include a full spectrum of oil dispensers, vaporizer cartridges and vaporizer kits, as well as topicals (http://ibn.fm/M0rsM).

For more information, visit the company’s website at www.FinCannaCapital.com